Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.
| Descriptor ID |
D054218
|
| MeSH Number(s) |
C04.557.337.428.600.620 C15.604.515.560.600.620 C20.683.515.528.600.620
|
| Concept/Terms |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T Cell Lymphoblastic Leukemia Lymphoma
- Leukemia, Lymphoblastic, Acute, T Cell
- Leukemia, Lymphoblastic, Acute, T-Cell
- Leukemia, Lymphocytic, Acute T Cell
- Leukemia, Lymphocytic, Acute, T-Cell
- Leukemia, T-Cell, Acute
- T-Lymphocytic Leukemia, Acute
- Acute T-Lymphocytic Leukemia
- Acute T-Lymphocytic Leukemias
- Leukemia, Acute T-Lymphocytic
- Leukemias, Acute T-Lymphocytic
- T Lymphocytic Leukemia, Acute
- T-Lymphocytic Leukemias, Acute
- Lymphoblastic Leukemia, Acute, T-Cell
- Lymphocytic Leukemia, T Cell, Acute
- Lymphocytic Leukemia, T-Cell, Acute
- Precursor T-Cell Lymphoblastic Leukemia
- Precursor T Cell Lymphoblastic Leukemia
- Precursor T-Cell Lymphoblastic Lymphoma
- Precursor T Cell Lymphoblastic Lymphoma
- T-ALL
- T-Cell Leukemia, Acute
- Acute T-Cell Leukemia
- Acute T-Cell Leukemias
- Leukemia, Acute T-Cell
- Leukemias, Acute T-Cell
- T Cell Leukemia, Acute
- T-Cell Leukemias, Acute
- T-Cell Acute Lymphocytic Leukemia
- Lymphoblastic Leukemia, Acute, T Cell
|
Below are MeSH descriptors whose meaning is more general than "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma".
This graph shows the total number of publications written about "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" by people in this website by year, and whether "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 3 | 2 | 5 |
| 2011 | 2 | 0 | 2 |
| 2012 | 3 | 0 | 3 |
| 2013 | 2 | 0 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 6 | 0 | 6 |
| 2023 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" by people in Profiles.
-
Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T-ALL. Leukemia. 2024 03; 38(3):491-501.
-
S1P-S1PR3-RAS promotes the progression of S1PR3hi TAL1+ T-cell acute lymphoblastic leukemia that can be effectively inhibited by an S1PR3 antagonist. Leukemia. 2023 10; 37(10):1982-1993.
-
Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia. Clin Cancer Res. 2023 08 15; 29(16):3151-3161.
-
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma. Curr Hematol Malig Rep. 2023 12; 18(6):217-225.
-
Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia. Leukemia. 2023 06; 37(6):1194-1203.
-
Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients. Haematologica. 2022 12 01; 107(12):2783-2793.
-
Tcf-1 promotes genomic instability and T cell transformation in response to aberrant ß-catenin activation. Proc Natl Acad Sci U S A. 2022 08 09; 119(32):e2201493119.
-
How I Diagnose Acute Leukemia of Ambiguous Lineage. Am J Clin Pathol. 2022 07 01; 158(1):27-34.
-
Acute lymphoblastic leukemia displays a distinct highly methylated genome. Nat Cancer. 2022 06; 3(6):768-782.
-
E Protein Transcription Factors as Suppressors of T Lymphocyte Acute Lymphoblastic Leukemia. Front Immunol. 2022; 13:885144.